Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials

References

• Kwan P, Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia 2001;42:1255-60
   PubMed Web of Science ®Google Scholar
• Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-19
   PubMed Web of Science ®Google Scholar
• Engelberts NH, Klein M, van der Ploeg HM, et al. Cognition and health-related quality of life in a well-defined subgroup of patients with partial epilepsy. J Neurol 2002;249:294-9
   PubMed Web of Science ®Google Scholar
• Johnson EK, Jones JE, Seidenberg M, et al. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004;45:544-50
   PubMed Web of Science ®Google Scholar
• Cramer JA, Blum D, Reed M, Fanning K; Epilepsy Impact Project Group. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav 2003;4:515-21
   PubMed Web of Science ®Google Scholar
• Xu X, Brandenburg NA, McDermott AM, et al. Sleep disturbances reported by refractory partial-onset epilepsy patients receiving polytherapy. Epilepsia 2006;47:1176-83
   PubMed Web of Science ®Google Scholar
• Kobau R, Zahran H, Thurman DJ, et al. Epilepsy surveillance among adults – 19 states, Behavioral Risk Factor Surveillance System, 2005. MMWR Surveill Summ 2008;57:1-20. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5706a1.htm[Last accessed 19 October 2010]
   PubMedGoogle Scholar
• McLaughlin DP, Pachana NA, McFarland K. Stigma, seizure frequency and quality of life: the impact of epilepsy in late adulthood. Seizure 2008;17:281-7
   PubMed Web of Science ®Google Scholar
• Modi AC, King AS, Monahan SR, et al. Even a single seizure negatively impacts pediatric health-related quality of life. Epilepsia 2009;50:2110-16
   PubMed Web of Science ®Google Scholar
• Poochikian-Sarkissian S, Sidani S, Wennberg RA, et al. Psychological impact of illness intrusiveness in epilepsy – comparison of treatments. Psychol Health Med 2008;13:129-45
   PubMedGoogle Scholar
• French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1252-60
   PubMed Web of Science ®Google Scholar
• French JA, Faught E. Rational polytherapy. Epilepsia 2009;50(Suppl 8):63-8
   PubMed Web of Science ®Google Scholar
• Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007;62:375-81
   PubMed Web of Science ®Google Scholar
• Treiman DM. Management of refractory complex partial seizures: current state of the art. Neuropsychiatr Dis Treat 2010;6:297-308
   PubMed Web of Science ®Google Scholar
• Callaghan BC, Anand K, Hesdorffer D, et al. Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol 2007;62:382-9
   PubMed Web of Science ®Google Scholar
• French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1261-73
   PubMed Web of Science ®Google Scholar
• Lyrica [prescribing information]. New York, NY: Pfizer Inc, 2009. Available at: http://www.pfizer.com/files/products/uspi_lyrica.pdf [Last accessed 24 February 2010]
   Google Scholar
• Stacey BR, Swift JN. Pregabalin for neuropathic pain based on recent clinical trials. Curr Pain Headache Rep 2006;10:179-84
   PubMedGoogle Scholar
• Patsalos PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 2000;85:77-85
   PubMed Web of Science ®Google Scholar
• Donato Di Paola E, Gareri P, Davoli A, et al. Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. Epilepsy Res 2007;75:112-21
   PubMed Web of Science ®Google Scholar
• Dudra-Jastrzebska M, Andres-Mach MM, Sielski M, et al. Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis. Eur J Pharmacol 2009;605:87-94
   PubMed Web of Science ®Google Scholar
• Kaminski RM, Matagne A, Patsalos PN, et al. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam. Epilepsia 2009;50:387-97
   PubMed Web of Science ®Google Scholar
• Elger CE, Brodie MJ, Anhut H, et al. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 2005;46:1926-36
   PubMed Web of Science ®Google Scholar
• Baulac M, Leon T, O'Brien TJ, et al. A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures. Epilepsy Res 2010;91:10-19
   PubMed Web of Science ®Google Scholar
• Commission on Classification and Terminology of the ILAE. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501
   PubMed Web of Science ®Google Scholar
• Brodie MJ. Pregabalin as adjunctive therapy for partial seizures. Epilepsia 2004;45(Suppl 6):19-27
   PubMed Web of Science ®Google Scholar
• Arroyo S, Anhut H, Kugler AR, et al. Pregabalin 1008-011 International Study Group. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004;45:20-7
   PubMed Web of Science ®Google Scholar
• Beydoun A, Uthman BM, Kugler AR, et al. Pregabalin 1008-009 Study Group. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 2005;64:475-80
   PubMed Web of Science ®Google Scholar
• French JA, Kugler AR, Robbins JL, et al. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003;60:1631-7
   PubMed Web of Science ®Google Scholar
• Mattson RH. Drug treatment of uncontrolled seizures. Epilepsy Res Suppl 1992;5:29-35
   PubMedGoogle Scholar
• Mohanraj R, Brodie MJ. Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol 2006;13:277-82
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Wilson EA, Wesche DL, et al. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia 2005;46:1407-13
   PubMed Web of Science ®Google Scholar